KCS/Dry Eye Syndrome Signs, Symptoms & Treatment Options for Pets
January 20th, 2015 | Posted in Medical Articles
What is KCS?
KCS is the abbreviation for “Keratoconjunctivitis Sicca”, the medical term for dry eye. When there is either inadequate tear production or abnormal distribution of tears, the eye surface becomes desiccated or “dried out”. Signs of KCS may include a red eye, squinting, crusty and/or mucoid discharge, or dull appearance to the cornea (clear outer dome of the eye).
What is so important about having normal tears?
The surface of the eye is covered by a thin layer of tears which perform several essential functions. The tears keep the surface of the cornea wet so that oxygen can be taken into the cells, rinse the surface of the eye clean, lubricate the eyelid movements and help control infection. When these actions are missing, the cornea is deprived of oxygen, irritated and prone to infection. The result is severe, sometimes permanent damage to the cornea. This can cause painful ulcerations, which may result in perforations and blindness or even loss of the eye. The eyelids and inner membrane (third eyelid) act as “windshield wipers” to spread the tears across the corneal “windshield” and to keep it clean. The tears then drain downward into tear duct openings and into the nose just as in humans. The proper combination of tear production and spreading is necessary to keep the cornea clear and healthy.
What Causes KCS?
The most common cause in dogs is immune-mediated inflammation of the lacrimal (tear) glands. Others include allergies, infections, hormonal deficiencies, injuries, abnormal growths, nerve damage, increased evaporation and certain medications that can decrease tear production from the glands or interfere with normal distribution of tears.
What Treatment is there for KCS?
Treatment must include both replacing the missing tear functions and stimulating more of your pet’s own tears. Some patients respond well to topical medication administered only 2-3 times daily, while others may require more frequent treatments to keep the eyes as healthy as possible. Of course, if the underlying cause can be identified it must also be treated.
Once KCS is diagnosed, medical treatment is instituted. The most common tear stimulant medications are topical cyclosporine (CsA) or tacrolimus. Both medications reduce tear gland inflammation and stimulate tear production. Tear stimulants are successful in increasing tear production in the majority of patients with immune-mediated KCS. Patients with very low to absent tear production respond less predictably to tear stimulants, have more complex treatment regimens and may require surgical management to preserve vision. Other medications may include topical steroids, artificial tear supplements, and eye washes.
Once a patient has KCS, medical therapy will alleviate the signs but will not often cure the disease. Affected dogs and cats usually need to be treated for life. Fortunately, most pets can be maintained on eye drops once or twice daily..
What can I expect after Treatment?
In many patients, once tear functions are restored, the surface health of the eye will improve and the cornea will regain its normal transparency. In other patients, there is some permanent scarring (cloudiness) and pigment that remains on the cornea.
How long does Treatment take?
Replacing the missing tear functions and improving your pet’s own tear production can take anywhere from a few days to several months. However, most patients with tear deficiency will need some type of therapy for the rest of their life.
What if Medical Treatment does not work?
Some animals will not respond to medications, especially if there has been long-term underlying inflammation or disease. In these cases the tear glad tissue often becomes more like fibrotic scar tissue and loses all ability to make and secrete tears. Other animals may have been born with a congenital malformation of the gland, or no gland at all (lacrimal gland aplasia), so there is just not enough functional tissue to adequately lubricate the eye. In these patients, a surgery called a parotid duct transposition (“PDT”) may be performed. This is a tedious surgery performed under general anesthesia and involves rerouting a salivary gland so its secretions empty onto the ocular surface instead of into the mouth. This provides a constant flow of wetness to the eye surface, but can also lead to mineral deposition on the cornea or around the eyelids.
